BMP9 promotes peri-implant osseointegration in beagle defects

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Bone morphogenetic proteins (BMPs) are crucial for bone regeneration.
• BMP2 is widely studied, but alternatives like BMP9 are being investigated for enhanced efficacy.
• Peri-implant defects require effective bone regeneration and osseointegration for implant success.

Purpose of the Study:

• To compare the in vivo bone regeneration and osseointegration efficacy of BMP9 versus BMP2.
• To evaluate these effects in a critical-size peri-implant defect model in beagle dogs.

Main Methods:

• Critical-size peri-implant defects were created in beagle dogs.
• Defects were treated with collagen sponge (CS) or deproteinized bovine bone mineral with collagen (OCS-BC), with or without BMP2 or BMP9.
• Bone regeneration and osseointegration were assessed via radiographic, histological, and biomechanical analyses after 8 weeks.

Main Results:

• BMP treatment significantly increased peri-implant bone mineralization and new bone formation.
• BMP9 showed comparable or superior results to BMP2 in promoting bone-to-implant contact (BIC) and osseointegration.
• Radiographic, histological, and biomechanical data confirmed enhanced bone regeneration and implant stability with BMP9, without significant inflammation.

Conclusions:

• BMP9 demonstrated efficacy comparable to BMP2 in promoting bone regeneration and osseointegration in a peri-implant defect model.
• BMP9 may offer more reproducible osseointegration outcomes across different scaffold materials.